
Alkemi Growth Capital Plans $125-150 Million Third Fund Launch in 2027
What Happened?
Alkemi Growth Capital is set to launch its third fund in 2027, targeting $125-150 million to invest in healthcare innovation and deep-tech startups. Founding partner Alka Goel mentioned that fundraising discussions are yet to formally begin.
Key points
- Alkemi's third fund aims to raise between $125 million and $150 million.
- The firm has previously raised funds of $40 million and $75 million.
- Alkemi has invested in 14 companies through its current $75 million fund.
- The average investment size is expected to increase to ₹25-40 crore.
- Alkemi's portfolio includes companies like Redcliffe Labs and Medvital.
- Preventive healthcare is a major investment theme for Alkemi.
Key insights
- Increased investment in healthcare could lead to more innovative solutions in the sector.
- Alkemi's focus on deep-tech may attract more startups in this emerging field.
- The growing consumer awareness in preventive healthcare may drive further investments.
Why it matters
The launch of the third fund could significantly enhance investment in healthcare innovation.
Tags
Entities
Source
Business Standard


